EcoDrugPlus

Ribosomal Protein L23

Ensembl ID : ENSCDRG00005019895
Gene Symbol: RPL23
3 Cross references
210 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSCDRG00005001256
Gene Symbol: RPL24
3 Cross references
220 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSCDRG00005015669
Gene Symbol: RPL26
1 Cross references
230 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSCDRG00005011005
Gene Symbol: RPL27
3 Cross references
187 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSCDRG00005007899
Gene Symbol: RPL28
2 Cross references
213 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSCDRG00005009291
Gene Symbol: RPL30
3 Cross references
213 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSCDRG00005020695
Gene Symbol: RPL35A
3 Cross references
157 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSCDRG00005013311
Gene Symbol: RPL36A
3 Cross references
344 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSCDRG00005016487
Gene Symbol: RPL37
3 Cross references
165 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSCDRG00005016271
Gene Symbol: RPL37A
3 Cross references
108 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSCDRG00005013632
Gene Symbol: RPL38
1 Cross references
247 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSCDRG00005013320
Gene Symbol: RPL39
2 Cross references
109 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).